Trust Stamp Inc (NASDAQ:IDAI, ISE:AIID) has filed a US provisional patent application for an artificial intelligence-based medical diagnostic support system aimed at helping physicians evaluate diagnoses while addressing common limitations of large language models (LLMs). The patent application, titled "Medical Diagnostic Assurance System" (MDAS), was filed on June 15, 2026.




